Publication | Closed Access
Predictors of response to Infliximab in children with luminal Crohn's disease
29
Citations
30
References
2014
Year
The cumulative probability of durable response to IFX in luminal CD was 83%, 74% and 70% after 1, 2, and 3years on IFX maintenance therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1